21
Participants
Start Date
June 30, 2006
Primary Completion Date
December 31, 2012
Study Completion Date
March 31, 2014
Velcade and Vorinostat
Subjects will receive one of 3 doses of Velcade (at a dose of 1.0 - 1.6 mg/m2 once weekly for 3 weeks) and one of 4 doses of Vorinostat (at a dose of 100mg every day 3 times a week for 3 weeks to 300mg twice per day, 3 times per week for 3 weeks). Doses determined by a predetermined escalation schedule.
University of Virginia, Charlottesville
University of Virginia
OTHER